Analyst upgrades: Goldman Sachs, Alexza Pharma, SAP
Posted Mar 18th 2008 11:50AM by Eric Buscemi
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Goldman Sachs Group (GS), Tyson Foods'A' (TSN), Bear Stearns Cos (BSC)
.gif)
MOST NOTEWORTHY: Goldman Sachs, Alexza Pharma and SAP AG were today's noteworthy upgrades:
- Wachovia upgraded Goldman Sachs (NYSE: GS) to Outperform from Market Perform, as they believe Goldman has a superior capital position relative to competitors and will likely benefit more than any firm from Bear Stearns' (NYSE: BSC) collapse. They have a $180-$185 target range for the stock.
- Following Alexza Pharma's (NASDAQ: ALXA) Q4 report, JMP Securities said they have reduced concerns regarding Loxapine timelines and risks. The firm raised Alexza to Outperform from Market Perform.
- SAP AG (NYSE: SAP) was upgraded to Outperform from Market Perform at Bernstein on valuation and a positive view on fundamentals.
OTHER UPGRADES:
- Tyson Foods (NYSE: TSN) was raised to Overweight from Equal Weight at Stephens.
- Citigroup upgraded Teekay Shipping (NYSE: TK) and General Maritime (GMR) to Buy from Hold.
- RiskMetrics (NYSE: RMG) was upgraded to Buy from Neutral at Banc of America.
Tags: alexza, alxa, analyst, bear stearns, BearStearns, bsc, goldman sachs, GoldmanSachs, gs, riskmetrics, rmg, sap, teekay, tk, tsn, tyson, upgrade
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
